
News|Articles|June 10, 2026
Q&A: How Specialty Pharmacies Are Evolving Into Disease Management Hubs
Specialty pharmacies are moving beyond the dispense—layering SDOH screening, adherence coaching, and chronic disease management into the patient journey.
Advertisement
Advertisement
For decades, the specialty pharmacy's core value proposition was straightforward: get a complex, high-cost medication into the hands of the right patient at the right time. That mission remains essential, but as the financial and clinical stakes of specialty therapeutics escalate, a growing number of health system specialty pharmacies are pushing past the dispense model, positioning themselves as longitudinal care partners embedded in the clinical workflow.
Related to this article

Episode 4 of Supply Chain Signal examines PhRMA’s legal challenge to CMS ’ GLOBE model and whether manufacturers can lower costs, expand U.S. production and strengthen supply chain resilience all at once.

Cencora’s Matt Sample and Gregg Gorniak explain why AI should recommend, not decide, and why pharma needs an agent strategy before chasing use cases.

With a lawsuit, a House delay bill and drugmaker intervention motions in play, here's where HRSA's 340B rebate pilot stands ahead of Jan. 1.

In this week's Pharma Pulse, Cencora agrees to acquire American Oncology Network, five major employers back electronic prior authorization for self-funded health plans and FDA finalizes its guidance on prescription drug apps and software.

CSafe's Aaron Mantia explains how lane, temperature range, duration and product cost shape thermal protection choices for bulk air cargo.

At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how automation cuts human touches, enforces quarantine and consolidates cold storage.

PAXAFE's Mark Talens explains why real-time visibility starts with process redesign and how it speeds cold chain disposition decisions.
Advertisement
Advertisement

